We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$20.4B
This Fund
S&P 500
This Quarter
Est. Return
+3.52%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$22.6B
AUM Growth
-$1.4B
(-5.9%)
Cap. Flow
-$1.51B
Cap. Flow
% of AUM
-6.68%
Top 10 Holdings %
Top 10 Hldgs %
15%
Holding
2,817
New
156
Increased
736
Reduced
766
Closed
891
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$108M |
| 2 |
Humana
HUM
|
+$88.8M |
| 3 |
Intercontinental Exchange
ICE
|
+$79.5M |
| 4 |
Wyndham Hotels & Resorts
WH
|
+$57.1M |
| 5 |
Fortune Brands Innovations
FBIN
|
+$56.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$180M |
| 2 |
AET
Aetna Inc
AET
|
+$109M |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$102M |
| 4 |
Johnson & Johnson
JNJ
|
+$98.9M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$86.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.5% |
| 2 | Healthcare | 16.62% |
| 3 | Financials | 13.99% |
| 4 | Consumer Discretionary | 10.59% |
| 5 | Industrials | 10.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Invesco
IVZ
$13.3B
| $30.6M | 0.14% |
1,153,628
-622,341
| -35% | -$17.9M |
|
|
CELG
227
DELISTED
Celgene Corp
CELG
| $30M | 0.13% |
378,289
-401,758
| -52% | -$33.4M |
|
228
Costco
COST
$415B
| $29.5M | 0.13% |
141,206
+4,780
| +4% | +$944K |
|
|
ALE
229
DELISTED
Allete
ALE
| $29.3M | 0.13% |
378,310
-37,219
| -9% | -$2.79M |
|
|
ESRX
230
DELISTED
Express Scripts Holding Company
ESRX
| $28.8M | 0.13% |
372,765
-49,391
| -12% | -$3.71M |
|
231
RPM International
RPM
$13.7B
| $28.6M | 0.13% |
489,989
+135,703
| +38% | +$6.81M |
|
|
ARRS
232
DELISTED
ARRIS International plc Ordinary Shares
ARRS
| $28.5M | 0.13% |
1,166,628
+39,031
| +3% | +$1.03M |
|
233
Amazon
AMZN
$2.5T
| $28.2M | 0.13% |
332,220
-1,060
| -0.3% | -$84.1K |
|
234
Parker-Hannifin
PH
$125B
| $28.2M | 0.12% |
181,140
-871
| -0.5% | -$149K |
|
235
Cigna
CI
$76.6B
| $28.1M | 0.12% |
165,362
+131,983
| +395% | +$22.8M |
|
|
FNSR
236
DELISTED
Finisar Corp
FNSR
| $27.8M | 0.12% |
1,547,161
+721,583
| +87% | +$11.9M |
|
237
Agilent Technologies
A
$39.1B
| $27.7M | 0.12% |
447,884
+19,716
| +5% | +$1.29M |
|
238
US Commodity Index
USCI
$372M
| $27.5M | 0.12% |
629,880
-31,413
| -5% | -$1.38M |
|
239
Ormat Technologies
ORA
$6.11B
| $27.5M | 0.12% |
517,197
+18,505
| +4% | +$1.01M |
|
240
Celanese
CE
$5.09B
| $27.5M | 0.12% |
247,512
+26,802
| +12% | +$2.96M |
|
241
CME Group
CME
$92.2B
| $27.4M | 0.12% |
167,321
+102,052
| +156% | +$16.7M |
|
242
Robert Half
RHI
$3.61B
| $27.2M | 0.12% |
418,200
-32,354
| -7% | -$2.05M |
|
243
International Paper
IP
$22.3B
| $26.4M | 0.12% |
535,695
+36,394
| +7% | +$1.86M |
|
244
Synchrony
SYF
$23.7B
| $26.2M | 0.12% |
785,584
-75,344
| -9% | -$2.59M |
|
|
FMBI
245
DELISTED
First Midwest Bancorp Inc/IL
FMBI
| $26.2M | 0.12% |
1,027,225
+1,027,001
| +458,483% | +$26.3M |
|
246
Nike
NKE
$61.9B
| $26M | 0.12% |
326,108
-45,688
| -12% | -$3.22M |
|
247
Henry Schein
HSIC
$9.74B
| $25.8M | 0.11% |
452,625
+448,578
| +11,084% | +$25.3M |
|
248
Fidelity National Information Services
FIS
$21.5B
| $25.7M | 0.11% |
242,723
+239,212
| +6,813% | +$24.3M |
|
249
Lockheed Martin
LMT
$134B
| $25.7M | 0.11% |
87,069
-899
| -1% | -$290K |
|
250
Qualcomm
QCOM
$176B
| $25.7M | 0.11% |
457,862
-36,453
| -7% | -$2.03M |
|
Similar funds
SLAM
EWA
MIC
P
OSAM
CB
EIM
Glenmede Trust's Q2 2018 Portfolio in Review
As of Q2 2018, Glenmede Trust held 2,817 positions worth $22.6B, down 5.9% from $24B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Glenmede Trust withdrew a net $1.51B in Q2 2018, closing 891 positions and reducing 766 holdings. Its most notable exit was iShares MSCI EAFE ETF, an estimated $75.1M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Glenmede Trust opened a new position in Wyndham Hotels & Resorts worth $54.6M.
- Glenmede Trust's largest Q2 2018 buy was Wyndham Hotels & Resorts: 928,051 shares worth $54.6M.
- Glenmede Trust added most to Walt Disney in Q2 2018, an estimated $108M increase.
- Glenmede Trust's biggest Q2 2018 reduction was ExxonMobil, cutting an estimated $180M.
- Glenmede Trust fully exited iShares MSCI EAFE ETF in Q2 2018, selling an estimated $75.1M.
- Glenmede Trust's ten largest holdings make up 15% of its $22.6B portfolio in Q2 2018.
- Glenmede Trust opened 156 new positions and closed 891 in Q2 2018.
- Glenmede Trust's portfolio value fell 5.9% quarter-over-quarter to $22.6B.
Based on Glenmede Trust's 13F filing for Q2 2018, filed 15 Aug 2018.